Stay updated on SPL7013 Gel in BV Recurrence Prevention Clinical Trial

Sign up to get notified when there's something new on the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:59:16.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page. No other content or functionality appears to be affected.
    Difference
    0.0%
    Check dated 2026-03-18T17:48:11.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    - Revision: v3.4.3 added; v3.4.2 removed.
    Difference
    0.0%
    Check dated 2026-03-11T16:48:23.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The notice about government funding lapse was removed.
    Difference
    0.2%
    Check dated 2026-02-11T06:17:59.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with NIH Clinical Center operating status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T05:12:41.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    - Added a Show glossary option and updated revision metadata to v3.4.0, with No FEAR Act Data removed.
    Difference
    0.3%
    Check dated 2026-01-28T02:47:36.000Z thumbnail image

Stay in the know with updates to SPL7013 Gel in BV Recurrence Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page.